Brand Post

NOTICE TO DISREGARD — Bright Meds

By GlobeNewswire

NEW YORK, January, Feb. 04, 2026 (GLOBE NEWSWIRE) — We are advised by Bright Meds that journalists and other readers should disregard the news release, “Brightmeds Tirzepatide Investigated: Is It Safe and Legit for Weight Loss? Exploring Safety, Side Effects, and Results (2026 Analysis)” issued January 21, 2026, 10:06 ET, over GlobeNewswire.

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. NYnewscast.com takes no editorial responsibility for the same.

GlobeNewswire

GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe